The global market for Intravitreal Injectable was valued at US$ 17970 million in the year 2024 and is projected to reach a revised size of US$ 28700 million by 2031, growing at a CAGR of 7.1% during the forecast period.

Intravitreal Injectable Market

Intravitreal injectables are sterile pharmaceutical formulations administered directly into the vitreous humor of the eye using a fine needle. This route of administration allows for targeted delivery of medications—such as anti-VEGF agents, corticosteroids, or antibiotics—into the posterior segment of the eye, ensuring high local drug concentrations while minimizing systemic exposure. Intravitreal injections are commonly used to treat retinal diseases including age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and infectious endophthalmitis.

The global intravitreal injectable market has experienced steady growth in recent years, driven primarily by the rising prevalence of retinal disorders such as macular edema, age-related macular degeneration (AMD), and retinal vein occlusion (RVO). North America currently dominates the global market, holding a share of more than 50%, followed by Europe and Asia-Pacific, each with shares exceeding 40%.

In terms of drug types, anti-VEGF (vascular endothelial growth factor) therapies represent the largest and most significant market segment, contributing to over 85% of total market revenue. These agents are highly effective in inhibiting abnormal blood vessel growth in the retina, making them the standard of care for diseases like AMD and diabetic macular edema (DME). Other therapeutic classes such as corticosteroids and antibiotics play smaller roles, typically in more specialized or adjunctive treatment scenarios.

The largest clinical application of intravitreal injectables is for macular edema, which continues to see a rise in incidence linked to diabetes and aging populations worldwide. Macular degeneration and RVO are also major contributors to demand, reinforcing the importance of targeted ophthalmic treatments. The increase in awareness, earlier diagnosis, and improved accessibility to eye care services are further driving market expansion across both developed and emerging regions.

Looking ahead, the market is expected to grow steadily due to increasing disease burden and product innovation. Notably, new players such as Astellas Pharma have begun entering the market, signaling a shift toward broader competition and possibly next-generation therapies with extended efficacy and dosing intervals. Advances in drug delivery systems, longer-acting formulations, and biosimilars are expected to further shape the landscape and offer new growth opportunities.

This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.

The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by Drug, by Disease, by Formulation Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravitreal Injectable companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Drug, by Disease, and by regions.

Market Segmentation

Scope of Intravitreal Injectable Market Report

Report Metric	Details
Report Name	Intravitreal Injectable Market
Accounted market size in year	US$ 17970 million
Forecasted market size in 2031	US$ 28700 million
CAGR	7.1%
Base Year	year
Forecasted years	2026 - 2031
Segment by Drug	Anti-VEGF Agents Corticosteroids / Steroid Implants Thrombolytic / Enzymatic Agents Others
Segment by Formulation Type	Solution for Intravitreal Injection Suspension for Intravitreal Injection Others
Segment by Duration of Action	Short-acting (4–6 weeks) Medium-acting (8–12 weeks) Long-acting (> 6 months)
Segment by Disease	Macular Degeneration Macular Edema Uveitis Retinal Vein Occlusion Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, AbbVie (Allergan), Alimera Sciences, Roche, Bristol-Myers Squibb, Bayer, Bausch + Lomb, EyePoint Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Drug, by Disease, by Formulation Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravitreal Injectable company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Drug, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Disease, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Intravitreal Injectable Market growing?

Ans: The Intravitreal Injectable Market witnessing a CAGR of 7.1% during the forecast period 2026-2031.

What is the Intravitreal Injectable Market size in 2031?

Ans: The Intravitreal Injectable Market size in 2031 will be US$ 28700 million.

Who are the main players in the Intravitreal Injectable Market report?

Ans: The main players in the Intravitreal Injectable Market are Regeneron Pharmaceuticals, Bausch & Lomb, Novartis, AbbVie (Allergan), Alimera Sciences, Roche, Bristol-Myers Squibb, Bayer, Bausch + Lomb, EyePoint Pharmaceuticals

What are the Type segmentation covered in the Intravitreal Injectable Market report?

Ans: The Types covered in the Intravitreal Injectable Market report are Solution for Intravitreal Injection, Suspension for Intravitreal Injection, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Drug

1.2.1 Global Intravitreal Injectable Market Size Growth Rate by Drug: 2020 VS 2024 VS 2031

1.2.2 Anti-VEGF Agents

1.2.3 Corticosteroids / Steroid Implants

1.2.4 Thrombolytic / Enzymatic Agents

1.2.5 Others

1.3 Market by Formulation Type

1.3.1 Global Intravitreal Injectable Market Size Growth Rate by Formulation Type: 2020 VS 2024 VS 2031

1.3.2 Solution for Intravitreal Injection

1.3.3 Suspension for Intravitreal Injection

1.3.4 Others

1.4 Market by Duration of Action

1.4.1 Global Intravitreal Injectable Market Size Growth Rate by Duration of Action: 2020 VS 2024 VS 2031

1.4.2 Short-acting (4–6 weeks)

1.4.3 Medium-acting (8–12 weeks)

1.4.4 Long-acting (> 6 months)

1.5 Market by Disease

1.5.1 Global Intravitreal Injectable Market Growth by Disease: 2020 VS 2024 VS 2031

1.5.2 Macular Degeneration

1.5.3 Macular Edema

1.5.4 Uveitis

1.5.5 Retinal Vein Occlusion

1.5.6 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Intravitreal Injectable Market Perspective (2020-2031)

2.2 Global Intravitreal Injectable Growth Trends by Region

2.2.1 Global Intravitreal Injectable Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Intravitreal Injectable Historic Market Size by Region (2020-2025)

2.2.3 Intravitreal Injectable Forecasted Market Size by Region (2026-2031)

2.3 Intravitreal Injectable Market Dynamics

2.3.1 Intravitreal Injectable Industry Trends

2.3.2 Intravitreal Injectable Market Drivers

2.3.3 Intravitreal Injectable Market Challenges

2.3.4 Intravitreal Injectable Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intravitreal Injectable Players by Revenue

3.1.1 Global Top Intravitreal Injectable Players by Revenue (2020-2025)

3.1.2 Global Intravitreal Injectable Revenue Market Share by Players (2020-2025)

3.2 Global Top Intravitreal Injectable Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Intravitreal Injectable Revenue

3.4 Global Intravitreal Injectable Market Concentration Ratio

3.4.1 Global Intravitreal Injectable Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intravitreal Injectable Revenue in 2024

3.5 Global Key Players of Intravitreal Injectable Head office and Area Served

3.6 Global Key Players of Intravitreal Injectable, Product and Application

3.7 Global Key Players of Intravitreal Injectable, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Intravitreal Injectable Breakdown Data by Drug

4.1 Global Intravitreal Injectable Historic Market Size by Drug (2020-2025)

4.2 Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031)

5 Intravitreal Injectable Breakdown Data by Disease

5.1 Global Intravitreal Injectable Historic Market Size by Disease (2020-2025)

5.2 Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031)

6 North America

6.1 North America Intravitreal Injectable Market Size (2020-2031)

6.2 North America Intravitreal Injectable Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Intravitreal Injectable Market Size by Country (2020-2025)

6.4 North America Intravitreal Injectable Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intravitreal Injectable Market Size (2020-2031)

7.2 Europe Intravitreal Injectable Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Intravitreal Injectable Market Size by Country (2020-2025)

7.4 Europe Intravitreal Injectable Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Intravitreal Injectable Market Size (2020-2031)

8.2 Asia-Pacific Intravitreal Injectable Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Intravitreal Injectable Market Size by Region (2020-2025)

8.4 Asia-Pacific Intravitreal Injectable Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Intravitreal Injectable Market Size (2020-2031)

9.2 Latin America Intravitreal Injectable Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Intravitreal Injectable Market Size by Country (2020-2025)

9.4 Latin America Intravitreal Injectable Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intravitreal Injectable Market Size (2020-2031)

10.2 Middle East & Africa Intravitreal Injectable Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Intravitreal Injectable Market Size by Country (2020-2025)

10.4 Middle East & Africa Intravitreal Injectable Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Regeneron Pharmaceuticals

11.1.1 Regeneron Pharmaceuticals Company Details

11.1.2 Regeneron Pharmaceuticals Business Overview

11.1.3 Regeneron Pharmaceuticals Intravitreal Injectable Introduction

11.1.4 Regeneron Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025)

11.1.5 Regeneron Pharmaceuticals Recent Development

11.2 Bausch & Lomb

11.2.1 Bausch & Lomb Company Details

11.2.2 Bausch & Lomb Business Overview

11.2.3 Bausch & Lomb Intravitreal Injectable Introduction

11.2.4 Bausch & Lomb Revenue in Intravitreal Injectable Business (2020-2025)

11.2.5 Bausch & Lomb Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Intravitreal Injectable Introduction

11.3.4 Novartis Revenue in Intravitreal Injectable Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 AbbVie (Allergan)

11.4.1 AbbVie (Allergan) Company Details

11.4.2 AbbVie (Allergan) Business Overview

11.4.3 AbbVie (Allergan) Intravitreal Injectable Introduction

11.4.4 AbbVie (Allergan) Revenue in Intravitreal Injectable Business (2020-2025)

11.4.5 AbbVie (Allergan) Recent Development

11.5 Alimera Sciences

11.5.1 Alimera Sciences Company Details

11.5.2 Alimera Sciences Business Overview

11.5.3 Alimera Sciences Intravitreal Injectable Introduction

11.5.4 Alimera Sciences Revenue in Intravitreal Injectable Business (2020-2025)

11.5.5 Alimera Sciences Recent Development

11.6 Roche

11.6.1 Roche Company Details

11.6.2 Roche Business Overview

11.6.3 Roche Intravitreal Injectable Introduction

11.6.4 Roche Revenue in Intravitreal Injectable Business (2020-2025)

11.6.5 Roche Recent Development

11.7 Bristol-Myers Squibb

11.7.1 Bristol-Myers Squibb Company Details

11.7.2 Bristol-Myers Squibb Business Overview

11.7.3 Bristol-Myers Squibb Intravitreal Injectable Introduction

11.7.4 Bristol-Myers Squibb Revenue in Intravitreal Injectable Business (2020-2025)

11.7.5 Bristol-Myers Squibb Recent Development

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Intravitreal Injectable Introduction

11.8.4 Bayer Revenue in Intravitreal Injectable Business (2020-2025)

11.8.5 Bayer Recent Development

11.9 Bausch + Lomb

11.9.1 Bausch + Lomb Company Details

11.9.2 Bausch + Lomb Business Overview

11.9.3 Bausch + Lomb Intravitreal Injectable Introduction

11.9.4 Bausch + Lomb Revenue in Intravitreal Injectable Business (2020-2025)

11.9.5 Bausch + Lomb Recent Development

11.10 EyePoint Pharmaceuticals

11.10.1 EyePoint Pharmaceuticals Company Details

11.10.2 EyePoint Pharmaceuticals Business Overview

11.10.3 EyePoint Pharmaceuticals Intravitreal Injectable Introduction

11.10.4 EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025)

11.10.5 EyePoint Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Eyepoint Pharmaceuticals

Bayer

Regeneron Pharmaceuticals

List of Tables

Table 1. Global Intravitreal Injectable Market Size Growth Rate by Drug (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-VEGF Agents

Table 3. Key Players of Corticosteroids / Steroid Implants

Table 4. Key Players of Thrombolytic / Enzymatic Agents

Table 5. Key Players of Others

Table 6. Global Intravitreal Injectable Market Size Growth Rate by Formulation Type (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Solution for Intravitreal Injection

Table 8. Key Players of Suspension for Intravitreal Injection

Table 9. Key Players of Others

Table 10. Global Intravitreal Injectable Market Size Growth Rate by Duration of Action (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of Short-acting (4–6 weeks)

Table 12. Key Players of Medium-acting (8–12 weeks)

Table 13. Key Players of Long-acting (> 6 months)

Table 14. Global Intravitreal Injectable Market Size Growth by Disease (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Intravitreal Injectable Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 16. Global Intravitreal Injectable Market Size by Region (2020-2025) & (US$ Million)

Table 17. Global Intravitreal Injectable Market Share by Region (2020-2025)

Table 18. Global Intravitreal Injectable Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 19. Global Intravitreal Injectable Market Share by Region (2026-2031)

Table 20. Intravitreal Injectable Market Trends

Table 21. Intravitreal Injectable Market Drivers

Table 22. Intravitreal Injectable Market Challenges

Table 23. Intravitreal Injectable Market Restraints

Table 24. Global Intravitreal Injectable Revenue by Players (2020-2025) & (US$ Million)

Table 25. Global Intravitreal Injectable Market Share by Players (2020-2025)

Table 26. Global Top Intravitreal Injectable Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravitreal Injectable as of 2024)

Table 27. Ranking of Global Top Intravitreal Injectable Companies by Revenue (US$ Million) in 2024

Table 28. Global 5 Largest Players Market Share by Intravitreal Injectable Revenue (CR5 and HHI) & (2020-2025)

Table 29. Global Key Players of Intravitreal Injectable, Headquarters and Area Served

Table 30. Global Key Players of Intravitreal Injectable, Product and Application

Table 31. Global Key Players of Intravitreal Injectable, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Intravitreal Injectable Market Size by Drug (2020-2025) & (US$ Million)

Table 34. Global Intravitreal Injectable Revenue Market Share by Drug (2020-2025)

Table 35. Global Intravitreal Injectable Forecasted Market Size by Drug (2026-2031) & (US$ Million)

Table 36. Global Intravitreal Injectable Revenue Market Share by Drug (2026-2031)

Table 37. Global Intravitreal Injectable Market Size by Disease (2020-2025) & (US$ Million)

Table 38. Global Intravitreal Injectable Revenue Market Share by Disease (2020-2025)

Table 39. Global Intravitreal Injectable Forecasted Market Size by Disease (2026-2031) & (US$ Million)

Table 40. Global Intravitreal Injectable Revenue Market Share by Disease (2026-2031)

Table 41. North America Intravitreal Injectable Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. North America Intravitreal Injectable Market Size by Country (2020-2025) & (US$ Million)

Table 43. North America Intravitreal Injectable Market Size by Country (2026-2031) & (US$ Million)

Table 44. Europe Intravitreal Injectable Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Europe Intravitreal Injectable Market Size by Country (2020-2025) & (US$ Million)

Table 46. Europe Intravitreal Injectable Market Size by Country (2026-2031) & (US$ Million)

Table 47. Asia-Pacific Intravitreal Injectable Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 48. Asia-Pacific Intravitreal Injectable Market Size by Region (2020-2025) & (US$ Million)

Table 49. Asia-Pacific Intravitreal Injectable Market Size by Region (2026-2031) & (US$ Million)

Table 50. Latin America Intravitreal Injectable Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 51. Latin America Intravitreal Injectable Market Size by Country (2020-2025) & (US$ Million)

Table 52. Latin America Intravitreal Injectable Market Size by Country (2026-2031) & (US$ Million)

Table 53. Middle East & Africa Intravitreal Injectable Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Middle East & Africa Intravitreal Injectable Market Size by Country (2020-2025) & (US$ Million)

Table 55. Middle East & Africa Intravitreal Injectable Market Size by Country (2026-2031) & (US$ Million)

Table 56. Regeneron Pharmaceuticals Company Details

Table 57. Regeneron Pharmaceuticals Business Overview

Table 58. Regeneron Pharmaceuticals Intravitreal Injectable Product

Table 59. Regeneron Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 60. Regeneron Pharmaceuticals Recent Development

Table 61. Bausch & Lomb Company Details

Table 62. Bausch & Lomb Business Overview

Table 63. Bausch & Lomb Intravitreal Injectable Product

Table 64. Bausch & Lomb Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 65. Bausch & Lomb Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Intravitreal Injectable Product

Table 69. Novartis Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. AbbVie (Allergan) Company Details

Table 72. AbbVie (Allergan) Business Overview

Table 73. AbbVie (Allergan) Intravitreal Injectable Product

Table 74. AbbVie (Allergan) Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 75. AbbVie (Allergan) Recent Development

Table 76. Alimera Sciences Company Details

Table 77. Alimera Sciences Business Overview

Table 78. Alimera Sciences Intravitreal Injectable Product

Table 79. Alimera Sciences Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 80. Alimera Sciences Recent Development

Table 81. Roche Company Details

Table 82. Roche Business Overview

Table 83. Roche Intravitreal Injectable Product

Table 84. Roche Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 85. Roche Recent Development

Table 86. Bristol-Myers Squibb Company Details

Table 87. Bristol-Myers Squibb Business Overview

Table 88. Bristol-Myers Squibb Intravitreal Injectable Product

Table 89. Bristol-Myers Squibb Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 90. Bristol-Myers Squibb Recent Development

Table 91. Bayer Company Details

Table 92. Bayer Business Overview

Table 93. Bayer Intravitreal Injectable Product

Table 94. Bayer Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 95. Bayer Recent Development

Table 96. Bausch + Lomb Company Details

Table 97. Bausch + Lomb Business Overview

Table 98. Bausch + Lomb Intravitreal Injectable Product

Table 99. Bausch + Lomb Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 100. Bausch + Lomb Recent Development

Table 101. EyePoint Pharmaceuticals Company Details

Table 102. EyePoint Pharmaceuticals Business Overview

Table 103. EyePoint Pharmaceuticals Intravitreal Injectable Product

Table 104. EyePoint Pharmaceuticals Revenue in Intravitreal Injectable Business (2020-2025) & (US$ Million)

Table 105. EyePoint Pharmaceuticals Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Intravitreal Injectable Picture

Figure 2. Global Intravitreal Injectable Market Size Comparison by Drug (2020-2031) & (US$ Million)

Figure 3. Global Intravitreal Injectable Market Share by Drug: 2024 VS 2031

Figure 4. Anti-VEGF Agents Features

Figure 5. Corticosteroids / Steroid Implants Features

Figure 6. Thrombolytic / Enzymatic Agents Features

Figure 7. Others Features

Figure 8. Global Intravitreal Injectable Market Size Comparison by Formulation Type (2020-2031) & (US$ Million)

Figure 9. Solution for Intravitreal Injection Features

Figure 10. Suspension for Intravitreal Injection Features

Figure 11. Others Features

Figure 12. Global Intravitreal Injectable Market Size Comparison by Duration of Action (2020-2031) & (US$ Million)

Figure 13. Short-acting (4–6 weeks) Features

Figure 14. Medium-acting (8–12 weeks) Features

Figure 15. Long-acting (> 6 months) Features

Figure 16. Global Intravitreal Injectable Market Size by Disease (2020-2031) & (US$ Million)

Figure 17. Global Intravitreal Injectable Market Share by Disease: 2024 VS 2031

Figure 18. Macular Degeneration Case Studies

Figure 19. Macular Edema Case Studies

Figure 20. Uveitis Case Studies

Figure 21. Retinal Vein Occlusion Case Studies

Figure 22. Others Case Studies

Figure 23. Intravitreal Injectable Report Years Considered

Figure 24. Global Intravitreal Injectable Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 25. Global Intravitreal Injectable Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Intravitreal Injectable Market Share by Region: 2024 VS 2031

Figure 27. Global Intravitreal Injectable Market Share by Players in 2024

Figure 28. Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Intravitreal Injectable Revenue in 2024

Figure 30. North America Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. North America Intravitreal Injectable Market Share by Country (2020-2031)

Figure 32. United States Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Canada Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Intravitreal Injectable Market Share by Country (2020-2031)

Figure 36. Germany Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. France Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. U.K. Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Italy Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Russia Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Ireland Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Intravitreal Injectable Market Share by Region (2020-2031)

Figure 44. China Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Japan Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. South Korea Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Southeast Asia Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. India Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Australia & New Zealand Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Intravitreal Injectable Market Share by Country (2020-2031)

Figure 52. Mexico Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Brazil Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Intravitreal Injectable Market Share by Country (2020-2031)

Figure 56. Israel Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. UAE Intravitreal Injectable Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Regeneron Pharmaceuticals Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 60. Bausch & Lomb Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 61. Novartis Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 62. AbbVie (Allergan) Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 63. Alimera Sciences Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 64. Roche Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 65. Bristol-Myers Squibb Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 66. Bayer Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 67. Bausch + Lomb Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 68. EyePoint Pharmaceuticals Revenue Growth Rate in Intravitreal Injectable Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Intravitreal Injection Market Research Report 2024

Global Robotic Intravitreal Injection System Market Research Report 2024

Global Intravitreal Injection of Anti VEGF Drugs Market Research Report 2024

Global Intraocular Injections Market Research Report 2024

Global Anti VEGF Intravitreal Drugs Market Research Report 2024

Global Implantable Ophthalmic Drugs Market Research Report 2025

Global Ranibizumab Injection Market Research Report 2024

Global Injectable Regenerative Graft Market Research Report 2024

Retinal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intravitreal Implant Market Research Report 2024

Global Retinal Vasculitis Treatment Market Research Report 2025

Global Cytomegalovirus Retinitis Treatment Market Research Report 2024

Global Vitreo Retinal Prefilled Silicone Oil Syringe Market Insights Forecast to 2030

Vitreo Retinal Surgery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Retinal Dystrophy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Disposable Intraocular Lens Injector Market Research Report 2024

Ophthalmic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions